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ABSTRACT   
The aging process deleteriously alters the structure and function of dermal collagen. These 
alterations result in thinning, fragility, wrinkles, laxity, impaired wound healing, and a 
microenvironment conducive to cancer. However, the key factors responsible for these changes 
have not been fully elucidated and relevant models for the study of skin aging progression are 
lacking. CCN1, a secreted extracellular matrix (ECM) associated matricellular protein, is 
elevated in dermal fibroblasts in aged human skin. Towards constructing a mouse model to study 
key factors involved in skin aging progression, we d monstrate that transgenic mice, with 
selective expression of CCN1 in dermal fibroblasts (COL1A2-CCN1), display accelerated skin 
dermal aging. The aged phenotype in COL1A2-CCN1 mice resembles aged human dermis: the 
skin is wrinkled, and the dermis is thin and composed of loose, disorganized, and fragmented 
collagen fibrils. These dermal alterations reflect reduced production of collagen due to impaired 
TGF-β signaling and increased expression of matrix metalloproteinases, driven up induction of 
c-Jun/AP-1. Importantly, similar mechanisms drive human dermal aging. Taken together, the 
data demonstrate that elevated expression of CCN1 by dermal fibroblasts functions as a key 
mediator of dermal aging. The COL1A2-CCN1 mouse model provides a novel tool for 











As the average expected lifespan increases, the consequences of aging are becoming an 
increasingly prominent public health issue. Aging affects all individuals and is the highest risk 
factor for most human diseases (Kennedy t al., 2014), including skin diseases (Beauregard and 
Gilchrest, 1987). Histological and ultrastructural studies of aged skin have revealed prominent 
alterations in the collagen-rich dermal extracellular matrix (ECM), which comprises the bulk of 
skin (Jacob, 2003; Yaar and Gilchrest, 2001). These d l terious alterations include loss of dermal 
mass, due to reduced production (Quan et al., 2010b) and increased fragmentation (Fisher et al., 
2009) of dermal collagen fibrils. 
Collagen fibrils are responsible for the structural and mechanical support provided by the dermis. 
Collagen fibrils also serve as a substrate for cellular attachment, which critically regulates cell 
function (Plant et al., 2009; Sweeney et al., 2008). In addition, the dermal ECM serves as a 
repository for a variety of bioactive proteins. Therefore, age-related degeneration of dermal 
collagen fibrils broadly impacts skin function (Smith et al., 1962). Age-related alterations of 
collagen fibrils also create a tissue microenvironme t that is directly related to age-related skin 
pathologies, such as increased fragility (Ma et al., 2001), impaired vasculature support (Jacob, 
2003), poor wound healing (Eaglstein, 1989), and promotion of skin cancer (Rogers et al., 2015). 
We previously reported that the matricellular protein CCN1 is markedly elevated in aged human 
skin (Quan et al., 2006). CCN1 is the first member of the CCN protein family, which comprises 
six members, CCN1 to CCN6 (Ayer-Lelievre et al., 2001). Members of the CCN family exhibit 
diverse cellular functions, including regulation of cell proliferation, chemotaxis, apoptosis, 
adhesion, motility, ion transport, and ECM regulation (Jun and Lau, 2011). CCN1 has been 










synthesis of ECM proteins, and wound healing (Lau, 2011). CCN1 functions by interacting with 
multiple integrins in a cell-type and context-depend t manner.  
We have previously reported that CCN1 regulates collagen homeostasis through αVβ3 integrin 
in human skin fibroblasts (Qin et al., 2013). It has been reported that heparin sulfate 
proteoglycans (HSPGs) bind to CCN1 any may serve as co-receptors (Chen et al., 2000). CCN1 
interaction with integrin/HSPGs induces a diverse range of cellular responses including 
increasing intracellular levels of reactive oxygen species (ROS) (Chen et al., 2007). Chen et al. 
(EMBO, 2007) demonstrated that exogenously added CCN1 raises ROS levels via ROS 
generation and release from mitochondria, a phenomen that is known to contribute to an 
oxidative stress response. In adult human dermal fibroblasts, ROS negatively regulates collagen 
production (He et al., 2014), while in fibrogenic myofibroblasts ROS is involved in the 
stimulation of collagen production (Dosoki et al., 2017; Wermuth et al., 2019). Thus, it appears 
that the role of ROS in the regulation of collagen production by ROS is complex and dependent 
on multiple factors, including cell type, the presenc  of pro-inflammatory mediators, and tissue 
milieu. Knockout of CCN1 in mice is embryonic lethal. This lethality is primarily due to the 
impairment of ECM homeostasis which leads to failure of vascular development (Mo et al., 
2002).  
CCN1 is expressed predominantly in dermal fibroblasts in human skin (Quan et al., 2006), the 
major cells responsible for collagen homeostasis. Elevated expression of CCN1 in cultured 
primary adult human dermal fibroblasts causes alterations in the expression of ECM genes 
similar to those observed in the dermis of aged human skin (Quan et al., 2006).  
To explore the role of CCN1 in skin aging we created a transgenic mouse model that selectively 










sequences. COL1A2-CCN1 mice exhibit accelerated aging of the dermis, characterized by loss of 
and fragmentation of collagen fibrils, which closely resembles aged human skin. Mechanistic 
investigations revealed that CCN1-associated impairment of TGF-β signaling, the major 
regulator of collagen and other ECM components, contributes to dermal thinning through 
reduced production of collagen. Furthermore, the upregulation of the transcription factor c-
Jun/AP-1 contributes to collagen fibril fragmentation, through elevated expression of multiple 
matrix metalloproteinases (MMPs), in COL1A2-CCN1 mice. Thus, fibroblast-derived CCN1 
expression orchestrates key age-related changes in dermal ECM by dysregulating both 
production and homeostasis of collagen.  
RESULTS AND DISCUSSION 
Fibroblast expression of CCN1 induces age-related alterations in the dermal extracellular 
matrix 
COL1A2-CCN1 mice were generated using a DNA construct containing the protein-coding 
sequences of human CCN1 under the control of the regulatory sequences of the human COL1A2 
proximal gene promoter and upstream enhancer (Figure 1a), which is selectively expressed in 
fibroblasts (Bou-Gharios et al., 1996; Sonnylal et al., 2010). PCR-based genotyping identified 
nine COL1A2-CCN1 transgenic founders, and extensive CCN1 transgene expression was 
observed throughout the dermis as shown by immunohistology (Figure S1a), quantitative RT-
PCR (Figure S1b) and Western blot (Figure S1c). Three lines with similar CCN1 transgene 
expression in the skin (Figure S1C) were used for the s udies presented in this report. 
Newborn COL1A2-CCN1 mice were grossly normal in appearance, and histological evaluation 
revealed normal skin morphology (Figure S1A). However, by six months of age, all three lines 










reduced weight (Figure 1c, 20% less weight compared to control littermates), and wrinkles on 
their dorsal skin (Figure S2a). The development of the aged appearance began at approximately 
two months of age and gradually became more apparent during the following four months. The 
degree of the aged appearance paralleled the accumulation/increases of CCN1 protein in the skin 
(Figure 1d). 
Histological examination revealed dermal thinning i COL1A2-CCN1 mice by six months of age. 
Dermal thickness was reduced by 46%, compared to non-transgenic sex and age-matched 
littermates (Figure 1e). Masson’s trichrome (Figure 1f) and Sirius red (Figure S2b) staining, 
which visualize collagen fibrils, revealed reduced density of collagen fibrils in COL1A2-CCN1 
mice. Nanoscale analysis by atomic force microscopy (AFM) indicated that collagen fibrils were 
significantly fragmented and disorganized in COL1A2-CCN1 transgenic mice (Figure 1g). 
Collagen fibrils displayed an amorphous appearance, with loss of distinct longitudinal fibrillar 
structure and perpendicular striated pattern (referd to as D-spacing), which are characteristic 
topographic features of intact collagen fibrils. These structural alterations of collagen fibrils 
resemble those overserved in aged human skin (Qin et al., 2014; Quan et al., 2009). Quantitative 
analysis demonstrated that the average roughness of collagen fibrils, an indicator of collagen 
fibril organization, was 2.6-fold greater in COL1A2-CCN1 mice than in non-transgenic 
littermates (25 nm vs. 66 nm, Figure 1h).  
Importantly, the dermal features observed in COL1A2-CCN1 mice closely resemble alterations 
that are observed in the dermis of aged human skin,uch as aberrant collagen homeostasis (Qin
et al., 2013; Qin et al., 2014; Quan et al., 2006). This finding supports the concept that elevat d 
dermal expression of CCN1 is a critical driver of age-related dermal alterations.  











To examine possible molecular pathways that promote dermal thinning, we cultured dermal 
fibroblasts from COL1A2-CCN1 mice and control littermates. We found that fibroblasts from 
COL1A2-CCN1 mice express significantly less type I collagen mRNA (Figure 2a) and protein 
(Figure 2b). These data are consistent with reduced collagen fibril content and dermal thinning in 
COL1A2-CCN1 mice.  
The TGF-β pathway is the major regulator of dermal ECM production (Quan et al., 2010b). We 
investigated the potential involvement of TGF-β signaling in reduced expression of type I 
collagen in COL1A2-CCN1 mice fibroblasts. We first examined TGF-β-dependent Smad3 
phosphorylation, which plays a critical role in type I procollagen gene expression (Lakos et al., 
2004). Interestingly, TGF-β dependent Smad3 phosphorylation was significantly lower in dermal 
fibroblasts from COL1A2-CCN1 mice (Figure 2c). To elucidate the mechanism of impaired 
TGF-β signaling, we determined the gene expression of the major TGF-β pathway components, 
including TGF-β ligands, TGF-β receptors, and Smads. We found that levels of typeII TGF-β 
receptor (TβRII) mRNA (Figure 2d) and protein (Figure 2e) were selectively and significantly 
decreased by 57% and 70%, respectively, in COL1A2-CCN1 mice fibroblasts. In contrast, type I 
TGF-β receptor (TβRI) expression (Figures 2d and 2e) and expression of other TGF-β pathway 
components remained unchanged (Figure S3). Next, we est d the possibility that prevention of 
TβRII reduction should counteract impaired TGF-β signaling and thereby prevents 
downregulation of type I collagen. We found that restoration of impaired TGF-β/Smad signaling 
by infecting COL1A2-CCN1 fibroblasts with TβRII-expressing adenovirus partially reversed the 
downregulation of type I collagen mRNA (Figures 2f) and protein (Figure 2g) expression.  









signaling, which leads to a reduction of type I collagen in COL1A2-CCN1 mice fibroblasts. 
Consistent with this finding, we previously reported that TGF-β signaling is decreased in aged 
human skin, largely due to a reduction in TβRII (Fisher et al., 2016; Quan et al., 2006). Given 
that the TGF-β pathway is the major regulator of collagen production, it is likely that reduced 
collagen production and attendant dermal thinning in COL1A2-CCN1 mice is mediated, at least 
in part, by impaired TGF-β signaling in dermal fibroblasts. 
Impairment of TGF-β signaling, due to loss of TβRII in stromal fibroblasts, results in epithelial 
tumors in animal models (Achyut et al., 2013). In the case of skin cancer, ultraviolet (UV) 
irradiation from the sun is thought to be the major risk factor. As it relates to this study, UV 
irradiation simultaneously induces CCN1 (~15-fold) (Quan et al., 2010a) and inhibits expression 
of TβRII (reduced ~70%) in human skin dermal fibroblasts both in vivo and in vitro (Quan et al., 
2004). These data suggest that a concomitant increase of CCN1 and reduction of TβRII in aged 
dermal fibroblasts could promote age-related keratinocyte skin cancer, which is the most 
common cancer in adult Caucasians (Mackiewicz-Wysocka et al., 2013). 
Elevated MMP expression contributes to dermal collagen fibril damage in COL1A2-CCN1 
mice 
We next explored potential mechanisms leading to the fragmentation of collagen fibrils in 
COL1A2-CCN1 mice. We measured proteolytic activity, in conditioned media from COL1A2-
CCN1 and non-transgenic littermate fibroblasts, by collagen zymography. As shown in Figure 3a, 
COL1A2-CCN1 mice fibroblasts expressed significantly greater proteolytic activity than control 
fibroblasts. The family of mammalian MMPs is primarily esponsible for the degradation of the 
collagen-rich ECM. Therefore, we examined the ability of the MMP inhibitor GM6001 to 










substantially inhibited COL1A2-CCN1 mice fibroblast proteolytic activity, in a dose-dependent 
manner (Figure 3a). This suppression suggests that COL1A2-CCN1 mice fibroblasts express 
increased levels of MMPs. To ascertain which MMP family members are expressed by COL1A2-
CCN1 mice fibroblasts, we determined gene expression levels of the 24 mammalian MMPs. We 
found that expression of MMP-9, -10, -13, -24, and -27 were significantly elevated in fibroblasts 
from COL1A2-CCN1 mice compared to control fibroblasts (Figure 3B). Importantly, these 
changes resemble those in aged human skin, in which elevated CCN1 upregulates expression of 
MMPs (Qin et al., 2013; Quan et al., 2011). 
MMP-13, or collagenase-3, can initiate type I collagen fibril degradation by cleavage at a single 
site within the triple helix to generate 3/4 and 1/4 length fragments (Stickens et al., 2004). The 
fragments can be further degraded by MMP-9, also known as gelatinase B (Fanjul-Fernández et 
al., 2010). MMP-10, or stromelysin-2, degrades other ECM components as well as activates 
proMMP-13 and proMMP-9 by limited proteolysis (Nakamura et al., 1998). MMP-24 and -27 
are relatively less well characterized. MMP-27 contains a transmembrane domain with a unique 
C-terminal extension (CTE) that promotes its retention in the endoplasmic reticulum (Cominelli 
et al., 2014), while MMP-24 is a membrane-type MMP, also kn wn as MT5-MMP, which can 
activate pro-gelatinase A (proMMP-2) in tumors (Llano et al., 1999). Therefore, COL1A2-CCN1 
fibroblasts express elevated levels of MMPs that together can initiate and further degrade type I 
collagen fibrils. 
We next cultured COL1A2-CCN1 and control littermate fibroblasts in three-dimensio al collagen 
lattices and examined collagen fibril fragmentation by AFM. AFM images revealed that collagen 
fibrils in lattices containing control fibroblasts were intact and well-organized, displaying 
characteristic periodic D-banding (Figure 3c, left panel). In contrast, collagen fibrils in lattices 










middle left), similar to collagen fibrils in lattices treated with recombinant human MMP-1 
(Figure 3c, right panel). COL1A2-CCN1 mice fibroblast-mediated collagen fibril disruption was 
blocked by GM6001 (Figure 3c, middle right).  
AFM three-dimensional surface topography mapping indicated that collagen fibrils in lattices 
containing COL1A2-CCN1 mice fibroblasts were more disorganized (Figure 3d). Quantitative 
analysis of AFM data indicated that the average roughness (a measure of fibril organization) of 
collagen fibrils in lattices containing COL1A2-CCN1 mice fibroblasts was 2-fold greater than 
lattices containing control fibroblasts (66 nm vs. 127 nm).  
c-Jun/AP-1 contributes to dermal collagen damage in COL1A2-CCN1 mice through 
elevation of MMPs 
Three of the five MMPs that are elevated in COL1A2-CCN1 mice fibroblasts (MMP-9, -10 and -
13) are regulated by the transcription factor AP-1 (Benbow and Brinckerhoff, 1997). We 
determined the expression of c-Jun, a component of AP-1, and found significant increases in c-
Jun mRNA (Figure 4a) and protein (Figure 4b). In addition, AP-1 transcriptional activity, 
measured by a luciferase reporter, was elevated four-fold in COL1A2-CCN1 mice fibroblasts 
(Figure 4c). Importantly, we found that knockdown of c-Jun by two different c-Jun siRNAs 
(Figure S4) partially reversed the upregulation of multiple MMPs (Figure 4d). We have 
previously reported that multiple MMPs increase with age in the human dermis (Fisher et al., 
2009; Quan et al., 2009), and this increase is associated with elevated expression of c-Jun/AP-1 
(Qin et al., 2014). Taken together, these data indicate that CCN1 induction of MMPs likely 
involves the upregulation of c-Jun/AP-1.  
Our data demonstrate that CCN1 is specifically exprssed in dermal fibroblasts in mouse skin. 










ridges and thinning of the epidermis. We did not observe significant histological epidermal 
alterations in our COL1A2-CCN1 mice, although normal mouse epidermis is relatively thin and 
generally lacks distinct rete ridges, making changes in these features difficult to access. Human 
aging also results in graying and thinning of hair. We have not observed a hair phenotype in our 
COL1A2-CCN1 mice. As such, COL1A2-CCN1 mice are primarily a model of accelerated 
dermal aging.  
It is possible that the COL1A2-CCN1 cassette that drives CCN1 expression in dermal fibroblasts 
may express CCN1 in collagen-producing cells in tissues other than skin. To investigate the 
potential effects of CCN1 transgene expression in tissues other than skin, we performed detailed 
necropsy of all organs. Histopathological examination did not reveal significant alterations in 
connective tissues or other tissues (brain, lungs, heart, liver, kidneys, skeletal muscle, joint, bone, 
tendon, etc.) that distinguished wild-type control littermates from COL1A2-CCN1 mice (Table 
S1).  
In summary, we demonstrate that selective expression of CCN1 in dermal fibroblasts drives an 
accelerated aged phenotype in the dermis that closely resembles human aging (Figure 4e). This 
finding supports a causal link between CCN1 and skin dermal aging. The mechanism by which 
CCN1 acts is indirect, likely initiated by integrin outside in signaling (Chen et al., 2007) leading 
to MAP kinase pathway activation and biosynthesis of effectors (Chen et al., 2001) such as AP-1. 
The COL1A2-CCN1 mouse model provides a unique opportunity to identify and investigate 
initial molecular mechanisms and early markers of skin dermal aging. Such studies could lead to 
the development of novel preventative and ameliorative therapeutic strategies to improve skin 










MATERIALS AND METHODS 
Generation of COL1A2-CCN1 transgenic mice 
The COL1A2-CCN1 transgenic mice used in this study were produced by standard pronuclear 
injection of linear DNA into a fertilized mouse egg (C57BL/6, Jackson Labs) at the University of 
Michigan Transgenic Core. Briefly, a Sal1 fragment containing the human CCN1 was PCR 
amplified and cloned in the plasmid pCD3 containing the 6-kb enhancer and promoter of the 
COL1A2 gene, an IRES-lacZ reporter, and the murine protamine polyA signal (Bou-Gharios et 
al., 1996; Sonnylal et al., 2010). All cloning was verified by sequencing. Integration of the 
CCN1 transgene was assessed by genotyping of mouse tail DNA with specific primers for CCN1 
transgene (5’-AAC-CCT-GAG-TGC-CGC-CTT-GTG-AAA-3’ and 5’-ATT-GGC-ATG-CGG-
GCA-GTT-GTA-GTT-3’) and mouse β-globin (5'-CCA-ATC-TGC-TCA-CAC-AGG-ATA-
GAG-AGG-GCA-GG-3' and 5’-CCT-TGA-GGC-TGT-CCA-AGT-GAT-TCA-GGC-CAT-CG 
3') as a positive control. The COL1A2-CCN1 founders were crossed with C57BL/6 background 
breeders (Jackson Labs) for at least 6 generations. All experiments were performed in 6 months-
old sex-matched mice. Three lines with similar exprssion of CCN1 transgene (Figure S1c) were 
used for the studies presented in this report. All protocols for mouse experimentation were 
approved by the University of Michigan Institutional Animal Care and Use Committee. 
Histology and Immunohistology 
Mouse skin was embedded in OCT and cryo-sections (7µm) were stained with hematoxylin and 
eosin (H&E), Masson’s trichrome, or Sirius red by the standard procedures. The dermal 
thickness and collagen density (blue in Masson’s trichrome and red in Sirius red) were quantified 
by computerized image analysis (Image-pro Plus software, version 4.1, Media Cybernetics). 










Cruz Biotechnology, Santa Cruz, CA) (Quan et al., 2006), type I procollagen (EMD Millipore, 
Temecula, CA). Briefly, skin samples embedded in OCT were sectioned (7 µm), fixed in 2% 
paraformaldehyde, permeabilized with 0.5% Triton X-100 in phosphate-buffered saline (PBS), 
blocked with rabbit serum (5% in PBS) and incubated for one hour at room temperature with 
primary antibodies, followed by incubation with secondary antibody for one hour at room 
temperature. After staining, the slides were examined using a digital imaging microscope (Zeiss, 
Germany). The specificity of staining was determined by substituting isotype-control 
immunoglobulin (mouse IgG2a) for the primary antibodies. No detectable staining was observed 
with isotype-controls.  
Atomic force microscopy (AFM) imaging 
Mouse skin biopsies and three-dimensional collagen lattices were embedded in OCT and cryo-
sections (15µm) were mounted on microscope cover glass (1.2 mm diameter, Fisher Scientific 
Co., Pittsburgh, PA) for AFM image analysis.  AFM images were acquired using a Dimension 
Icon AFM system (Bruker-AXS, Madison, WI) in air using a silicon etched cantilever 
(NSC15/AIBS, MikroMasch, San Jose, CA) with a full tip cone angle ~40º and the tip radius of 
curvature ~10 nm. AFM images were acquired at a scan rate of 0.977 Hz, 512x512 pixel 
resolutions, as previously described (Qin et al., 2014). Collagen fibril’s average roughness (Ra) 
was analyzed using Nanoscope Analysis software (Nanoscope Analysis v120R1sr3, Bruker-
AXS). AFM images were obtained from the Electron Microbeam Analysis Laboratory (EMAL), 
University of Michigan College of Engineering, and analyzed using Nanoscope Analysis 
software (Bruker-AXS). 









Mouse dorsal skin was washed with cold phosphate-buff red saline (PBS) and sterilized with 
70% ethanol twice. The skin tissue was placed in an empty 100 mm petri, then dissected and 
minced with surgical scissors using sterile techniques under the hood. The tissue was placed in a 
flask and was incubated with 10ml of 0.25% trypsinizing solution (Sigma Chemical Co., St. 
Louis, MO) and 0.02% ethylene diamine tetraacetate (EDTA, Sigma Chemical Co.) at room 
temperature for 15 minutes. The trypsinizing solutin was replaced with fresh solution (10ml) 
and incubated for one hour. Isolated cells were colle ted following brief centrifugation and 
resuspended in Dulbecco's modified Eagle's minimal essential medium (DMEM; Life 
Technology Inc., Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; Sigma 
Chemical Co.), penicillin (100 U/ml), streptomycin (100 μg/ml) in a humidified incubator with 
5% CO2 at 37°C. Cells were cultured at sub-confluence and utilized between passages 2 and 4. 
Total RNA was isolated from mouse skin punch biopsy and dermal fibroblasts using a 
commercial kit (RNeasy mini kit, Qiagen, Chatsworth, CA) according to the manufacturer’s 
protocol. PCR template was prepared by reverse transc iption using Taqman Reverse 
Transcription kit (Applied Biosystems, Foster City, CA).  PCR was performed in duplicate with 
2 μl of cDNA for the genes of interest using TaqMan Universal PCR Master Mix kit (Applied 
Biosystems) and a 7300 sequence detector system (Applied Biosystems). PCR procedures were 
performed with a robotic workstation (Biomek 2000; Beckman Coulter, Inc., Hialeah, FL) to 
ensure accuracy and reproducibility. Type I procollagen and MMPs mRNA levels were 
normalized to the mRNA levels of the housekeeping gene, 36B4 (internal control). Type I 
procollagen and MMPs primers were purchased from Real-Time Primers (Elkins Park, PA). 
Human CCN1 primers; sense, 5’-TCAAAGACCTGTGGAACTGGTATC-3’, anti-sense primer, 
5’-CACAAATCC-GGGTTTCTTTCA-3’. 










Whole-cell proteins were extracted, and equal amounts of protein (~40 μg/lane) were resolved by 
6-12% gradient sodium dodecyl sulfate-polyacrylamide (SDS) gel electrophoresis and 
transferred to polyvinylidene difluoride membranes. Membranes were then blocked with PBST 
(0.1% Tween 20 in PBS) containing 5% nonfat milk for one hour at room temperature. Primary 
antibodies were incubated for one hour at room temperature. The following antibodies were used 
for Western blotting: type I procollagen (EMD Millipore), phospho-Smad3 (Cell Signaling 
Technology, Danvers, MA), total Smad3, CCN1, TβRI, TβRII, c-Jun (Santa Cruz 
Biotechnology) and β-actin (Sigma). The membranes were washed three tims with PBST 
solution and incubated with appropriate secondary antibodies for one hour at room temperature. 
After washing three times with PBST, the membranes w re developed with ECF (Vistra ECF 
Western blotting system, GE Health Care, Piscataway, NJ) following the manufacturer’s 
protocol. The membranes were scanned with a STORM PhosphorImager (Molecular Dynamics, 
Sunnyvale, CA), the intensities of each band were quantified using ImageQuant software (GE 
Health Care, Piscataway, NJ) and normalized to β-actin (control). Full-size Western blots are 
provided in Figure S5. 
Adenovirus infection, siRNA transfection, and AP-1 reporter assay 
TβRII adenovirus was purchased from Applied Biological Materials Inc. (Richmond, BC, 
Canada). TβRII adenovirus was amplified by transducing HEK293 cells and infected cells 
following the manufacture’s instruction. Control adenovirus was obtained from the University of 
Michigan Medical School Biomedical Research Core. Control non-silencing si RNA 
(AATTCTCCGAACGTGTCACGT) and c-Jun si RNA#1 (AAAGTCATGAACCACGTTAA) 
were purchased from Qiagen (Germantown, MD). c-Jun siRNA #2 
(AACTCATGCTAACGCAGCAGT) was purchased from Xeragon I c (Germantown, MD).  










Alto, CA). Mouse skin fibroblasts were transiently transfected si RNAs or AP-1 reporter 
construct for 48 hours by electroporation using dermal fibroblasts nucleofector kit (Amaxa 
Biosystems, Gaithersburg, MD) according to the manuf ct rer’s protocol.  Luciferase activity 
was measured by luciferase assay using an enhanced lu iferase assay kit (PharMingen 
International, San Diego, CA) according to the manuf ct rer’s protocol.  Aliquots containing 
identical β-galactosidase activity were used for each luciferas  assay. 
Three-dimensional (3D) collagen cultures and zymography assay 
3D collagen gels were prepared based on a previous publication with minor modifications (Qin 
et al., 2014).  Briefly, rat tail type-I collagen (2 mg/ml, BD Biosciences) was suspended in a 
medium cocktail (DMEM, NaHCO3 [44 mM], L-glutamine [4 mM], Folic Acid [9 mM]), and 
neutralized with 1N NaOH to pH 7.2.  Cells (0.5x106) were suspended in 2 ml collagen and 
medium cocktail solution and plated in a 35 mm bacterial culture dish. The collagen gels were 
placed in an incubator at 37°C for 30 minutes to all w collagen polymerization. The collagen 
gels were then incubated with 2 ml media (DMEM, 10% FBS) at 370C, 5% CO2.  To activate 
secreted MMP-1, collagen lattices were washed extensiv ly with PBS (at least three times for 30 
minutes) and then treated with Trypsin-EDTA (100 ng/ml, Invitrogen Life Technology, 
Carlsbad, CA) in serum-free media for 24-36 hours. 3D collagen gels were embedded in OCT 
and cryo-sections (15 µm) were analyzed for collagen fragmentation by AFM image analysis. 
For zymography assays, conditioned media from the cultured cells were concentrated and then 
analyzed by electrophoresis in the presence of 12% Zymogram (collagen) protein gel (Thermal 
Fisher Scientific, Waltham, MA). After electrophoresis, the gel was incubated in Zymogram 
Renaturing buffer (Thermal Fisher Scientific) for 30 minutes at room temperature with gentle 
agitation. After renaturing, the gel was incubated in developing buffer (Thermal Fisher 










R-250 (Thermal Fisher Scientific) solution. MMP inhibitor (GM6001, Santa Cruz 
Biotechnology) was used to test MMP-mediated proteoly ic activity. 
Statistical analysis 
Data are expressed as mean ± SEM. Comparisons were mad  with the unpaired t-test (two 
groups). ANOVA test was performed for multiple comparisons. All p values are two-tailed and 
considered significant when <0.05. 
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Figure 1. Transgene expression of CCN1 in dermal fibroblasts causes age-related 
alterations of the dermal aged phenotype in mouse skin dermis. (a) Schematic representation 
of the construct expressed in dermal fibroblasts. (b) Representative gross appearance of 6 months 
old COL1A2-CCN1 mouse (right) and their non-transgenic littermate control (CTRL) (left). (c) 
Bodyweight of COL1A2-CCN1 mice and their non-transgenic littermate control (CTRL) was 
measured at 6 months after birth (n = 6 mice per genotype). (d) Accumulation of CCN1 protein 
expression in COL1A2-CCN1 mice and their non-transgenic littermate control (CTRL) over six 
months. Inset shows representative Western blots. CCN1 protein relative levels were determined 
by quantification of band intensity after normalizat on to the internal control β-actin band 
intensity. (e) H&E staining in samples taken from non-transgenic littermate control (CTRL) and 
COL1A2-CCN1 mice, with representative images shown. The dermal thickness was quantified 
by computerized image analysis (Image-pro Plus software, version 4.1, Media Cybernetics, 
Rockville, MD). (f) Masson’s trichrome staining, representative images. The dermal collagenous 
extracellular matrix is stained blue, cells are stained red, and the nuclei black. Subcutaneous fat 
appears white. Collagen fibril staining (blue) per microscopic field was quantified by ImageJ 
software. (g) Atomic force microscopy of collagen fibrils. Scale bar = 200 nm. Representative 
images are shown. The blue arrowheads indicate intact collagen fibrils and red arrowheads 
indicate damaged collagen fibrils. (h) Dermal collagen fibril organization, measured as Collagen 
fibril average roughness (Ra, nm), was quantified using Nanoscope Analysis software 
(Nanoscope_Analysis_v120R1sr3, Bruker-AXS, Santa Barbar , CA). All results expressed as 










Figure 2. Reduced production of type I collagen and impaired TGF-β signaling in 
fibroblasts from COL1A2-CCN1 mice. Fibroblasts from six months old COL1A2-CCN1 mice 
and non-transgenic littermate control (CTRL) were cultured from dorsal skin. Fibroblasts from 
COL1A2-CCN1  and CTRL mice were analyzed for levels of (a) type I procollagen mRNA, (b) 
type I procollagen protein, (c) TGF-β induction of Smad3 phosphorylation, (d) type I (TβRI) and 
type II (TβRII) TGF-β receptor mRNA, and (e) TβRI and TβRII protein. mRNA and protein 
levels determined by real-time RT-PCR or Western analysis, respectively. mRNA or protein 
levels were normalized to 36B4 (internal housekeeping gene control) or β-actin (loading 
control), respectively. Inset shows representative Western blots. Restoration of impaired TGF-
β/Smad signaling by infecting COL1A2-CCN1 fibroblasts with TβRII-expressing adenovirus 
partially reversed the downregulation of type I collagen mRNA (f) and protein (g) expression. 
Mean ± SEM, n = 3 mice per genotype, *p < 0.05. 
Figure 3. Fibroblasts from COL1A2-CCN1 mice express elevated levels of collagen-
degrading matrix metalloproteinases (MMPs). (A and B) Fibroblasts from the dorsal skin of 
six months old COL1A2-CCN1 mice and non-transgenic littermate control (CTRL) were cultured 
in monolayer. (a) Proteolytic activities in fibroblast conditioned media were examined by 
zymography. Areas of protease activity appear as clear bands. Inhibition of proteolytic activity 
by MMP inhibitor GM6001 identified the presence of MMP proteolytic activity. Recombinant 
human matrix metalloproteinase 1 (rh-MMP-1) was used as a positive control. (b) MMP mRNA 
levels were determined by real-time RT-PCR. Levels were normalized to 36B4 (internal 
housekeeping gene control). (c and d) Fibroblasts from COL1A2-CCN1 and non-transgenic 
littermates (CTRL) were cultured in three-dimensional collagen lattices and the structure of the 
collagen fibrils was examined by atomic force microsc py (AFM) in different treatment 










damaged collagen fibrils. (d) Collagen fibril organization, measured by average roughness (Ra), 
was quantified using Nanoscope Analysis software (Nanoscope_Analysis_v120R1sr3, Bruker-
AXS, Santa Barbara, CA). All data expressed as mean ± SEM, n = 3 mice per genotype, *p < 
0.05. 
Figure 4. c-Jun/AP-1 contributes to dermal damage in COL1A2-CCN1 mice through 
elevation of MMPs. Fibroblasts from dorsal skin of six months old non-transgenic littermate 
control (CTRL) and COL1A2-CCN1 mice were cultured in monolayer. (a) c-Jun mRNA and (b) 
c-Jun protein levels were determined by real-time RT-PCR and Western analysis, respectively. 
Levels were normalized to 36B4 (internal housekeeping gene control) and β-actin (loading 
control). Inset shows representative Western blots. (c) An AP-1 reporter construct (pAP1-TA-
Luc) was transiently transfected by electroporation into control and COL1A2-CCN1 fibroblasts. 
After 48 hours, luciferase activity was measured to etermine AP-1 activity. (d) Knockdown of 
c-Jun by c-Jun siRNA partially reversed upregulation of multiple MMPs. Fibroblasts from six 
month old COL1A2-CCN1 mice were transiently transfected with control siRNA (CTRL) or c-
Jun siRNA #1 or #2 by electroporation. Cells were harvested 48 hours after transfection and 
analyzed for MMP mRNA levels by real-time RT-PCR. Levels normalized to 36B4 (internal 
housekeeping gene control). mean ± SEM, n=3, *p < 0.05 vs CTRL. (e) Model showing 
mechanisms by which elevated CCN1 leads to dermal ECM aging. All data expressed as mean ± 
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